Enliven Therapeutics, Inc. (ELVN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 872.63M |
| Enterprise Value | 774.13M |
| P/E Ratio | -28.02 |
| PEG Ratio | -1.89 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 6.37 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -31.22 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.21 |
| Return On Equity | -0.21 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -263,000 |
| EBITDA | -103.43M |
| Net Income | -103.69M |
| Diluted EPS | -1.83 |
| Total Cash | 452.4M |
| Total Cash/Share | 7.2 |
| Total Debt | 302,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 40.32 |
| Book Value Per Share | 7.22 |
| 52-Week Change | 126.52 |
| 52-Week High | 48.53 |
| 52-Week Low | 14.79 |
| Moving Average 50 Days | 41.75 |
| Moving Average 200 Days | 28.23 |
| Average Volume | 1.33M |
| Shares Outstanding | 69.84M |
| % Held by Institutions | 110.1 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | February 24, 2023 |